TheProfitWatch

INKT - MiNK Therapeutics, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
10.61 0.41 (3.86%) --- --- 0.0 (0.0%) --- 0.41 (3.86%) 0.0 (0.0%) 0.0 (0.0%)

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Market

Earnings & Ratios

Basic EPS:
-1.06
Diluted EPS:
-1.06
Basic P/E:
-10.3962
Diluted P/E:
-10.3962
RSI(14) 1m:
100.0
VWAP:
11.02
RVol:

Events

Period Kind Movement Occurred At

Related News